SANOFI PASTEUR SUPPORTS CANADIAN NURSES THROUGH MASTER’S SCHOLARSHIP

Error message

Warning: htmlspecialchars(): Invalid multibyte sequence in argument in check_plain() (line 1828 of /internet/sites/drupal-sanofi-pasteur-ca/includes/bootstrap.inc).

Toronto, ON – July 22, 2011 – Sanofi Pasteur Limited, Canada's oldest and largest vaccine company, is a proud sponsor of the Canadian Nurses Foundation (CNF), providing the foundation with a $5000 annual scholarship open to eligible students at a Master’s level who specialize in Public and Community Health. The CNF supports world-class Canadian healthcare by raising funds to advance nursing knowledge and research, and by recognizing professional excellence in Canada's nurses.

“Sanofi Pasteur appreciates the critical role nurses play in public health – both in terms of patient care and delivery of health services. We are very pleased to provide this scholarship fund to support nursing research and education,” said Mark Lievonen, President of Sanofi Pasteur Limited.

The Sanofi Pasteur Scholarship in Public and Community Health was established in 1990, and has since provided many nurse practitioners with the financial means to pursue further education or  complete valuable research in the area of public health.

“As Canada’s only national nursing foundation, the Canadian Nurses Foundation is pleased to partner with Sanofi Pasteur to administer this valuable scholarship fund in Public and Community Health,” said Hélène Sabourin, Executive Director of the Canadian Nurses Foundation. “The support we receive from donors and through partnerships with private industry helps us to increase the availability of funds for nursing research and education. This nursing knowledge is crucial to every aspect of patient care and health service delivery for all Canadians.”

Scholarship applicants are examined by the Merit Review Panel (MRP), a group of six external nurse educators from across the country, who then bring forward a recommendation to the CNF board of directors. Applicants for the Sanofi Pasteur Scholarship in Public and Community Health are evaluated on several different levels including academic achievement, leadership and quality of application.

Michelle Long, 2010/2011 recipient of the Sanofi Pasteur scholarship has experienced firsthand the benefit of the company’s commitment to public healthcare. “The scholarship allowed me to cover the costs associated with tuition, research and various resources while I worked full-time as a registered nurse and pursued graduate studies in nursing. It has been invaluable.”

For more information on how Sanofi Pasteur supports the CNF, as well as other community-based initiatives, please contact Nancy Simpson, Director of Communications at nancy.simpson@sanofipasteur.com or by phone at 416-667-2955.

About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information, please visit: www.sanofipasteur.com or http://www.sanofipasteur.us

About CNF: The Canadian Nurses Foundation (CNF) was created by the Canadian Nurses Association in 1962. The CNF is Canada’s only national nursing foundation devoted to better patient care and superior patient outcomes. CNF believes in a day when every Canadian receives the finest possible nursing care from our nurses who are supported through education, research and technology to perform at their very best. The mission of the CNF is to advance nursing knowledge and improve health care by providing research grants, awards, and scholarships to Canadian nurses and nursing students. We raise funds for our activities through partnerships with organizations and individuals who share our goals. The CNF continuously improves the quality of care in Canada by advancing the knowledge capital of essential health care professionals. http://www.cnf-fiic

Forward Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of such products candidates, the absence of guarantee that the products candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group’s ability to benefit from external growth opportunities as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2010. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.


Contacts:

Global Media Relations     Canadian Media Relations
Pascal Barollier     Nancy Simpson
T. +33-(0)4-37-37-50-38     T. + 1-416-667-2955
pascal.barollier@sanofipasteur.com     nancy.simpson@sanofipasteur.com
www.sanofipasteur.com     www.sanofipasteur.ca